|Monday, April 29, 2019|
|7:30 AM - 8:00 AM|
|8:00 AM - 10:00 AM|
Lecture: Molecular Diagnostics for Lymphoid Malignancies
• Different lymphoproliferative disorders arise from different stages of lymphocyte development. The audience will gain an understanding of how the stage of development and function of normal lymphocytes is related to the malignancies arising these different normal cell types.
|10:00 AM - 10:15 AM|
|10:15 AM - 12:15 PM|
Lecture: Autologous Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
• Understand how apheresis machines work.
|12:15 PM - 1:00 PM|
|1:00 PM - 3:00 PM|
Lecture: Molecular Pathology for Disease Diagnosis and Prognostication in Small Animal Cancers
• Understand how tissue collection, fixation and processing can impact molecular diagnostic pathology.
|3:00 PM - 3:15 PM|
|3:15 PM - 5:15 PM|
Lecture: Immunotherapy of Small Animal Cancers
• Understand the interaction of the immune system and tumor cells during cancer development.
|5:15 PM - 6:00 PM|
|Tuesday, April 30, 2019|
|7:25 AM - 11:45 AM|
Keynote Series: New and Emerging Therapeutic Advances for Small Animal Cancers
|7:30 AM - 8:30 AM|
Lecture: Rabacfosadine for Treatment of Lymphoma in Dogs
• Understand the regulatory status of rabacfosadine (Tanovea-CA1) and the legal implications of this status.
|8:30 AM - 9:30 AM|
Lecture: Unleashing anticancer T cells - is strength in numbers enough?
• Understand how next-generation recombinant technologies are designed to improve patient outcomes.
|9:30 AM - 9:45 AM|
|9:45 AM - 10:45 AM|
Lecture: Bispecific Targeting of EGFR and UPAR in Canine Hemangiosarcoma
• Understand what Bispecific Ligand Targeted Toxins are and how they work in cancer therapy.
|10:45 AM - 11:45 AM|
Lecture: Beta Adrenergic Antagonism to Treat Canine Hemangiosarcoma
• Understand that adrenergic receptor (AR) antagonists reduce hemangiosaroma cell viability through receptor-independent mechanisms.
|11:45 AM - 12:30 PM|
|12:30 PM - 2:30 PM|
Lecture: Advanced and Functional Cancer Imaging
• Introduce and discuss the currently-available molecular imaging techniques and modalities, providing an overview of advantages, limitations, feasibility/logistics and applicability to veterinary patients.
|2:30 PM - 2:45 PM|
|2:45 PM - 4:45 PM|
Lecture: Cancer Clinical Trial Design, Implementation, and Interpretation
• Instill an understanding of the aailable clinical trial designs used at carious stages of novel drug/technology development and to understand the pros and cons of each approach and under what circumstances they may or may not be appropriate.
|4:45 PM - 5:00 PM|
Final Discussion & Wrap Up